BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 18221253)

  • 1. Indoleamine 2,3-dioxygenase in transplantation.
    Mulley WR; Nikolic-Paterson DJ
    Nephrology (Carlton); 2008 Jun; 13(3):204-11. PubMed ID: 18221253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
    Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
    Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes.
    Belladonna ML; Puccetti P; Orabona C; Fallarino F; Vacca C; Volpi C; Gizzi S; Pallotta MT; Fioretti MC; Grohmann U
    Transplantation; 2007 Jul; 84(1 Suppl):S17-20. PubMed ID: 17632406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond.
    Orabona C; Grohmann U
    Methods Mol Biol; 2011; 677():269-80. PubMed ID: 20941617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indoleamine 2,3-dioxygenase: from catalyst to signaling function.
    Fallarino F; Grohmann U; Puccetti P
    Eur J Immunol; 2012 Aug; 42(8):1932-7. PubMed ID: 22865044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human myeloid dendritic cells are refractory to tryptophan metabolites.
    von Bubnoff D; Wilms H; Scheler M; Brenk M; Koch S; Bieber T
    Hum Immunol; 2011 Oct; 72(10):791-7. PubMed ID: 21699942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is IDO a key enzyme bridging the gap between tumor escape and tolerance induction?
    Löb S; Königsrainer A
    Langenbecks Arch Surg; 2008 Nov; 393(6):995-1003. PubMed ID: 18064486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of IFN-gamma-mediated tryptophan catabolism on solid organ transplantation.
    Brandacher G; Margreiter R; Fuchs D
    Curr Drug Metab; 2007 Apr; 8(3):273-82. PubMed ID: 17430115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecules in focus: indoleamine 2,3-dioxygenase.
    King NJ; Thomas SR
    Int J Biochem Cell Biol; 2007; 39(12):2167-72. PubMed ID: 17320464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells.
    Hill M; Tanguy-Royer S; Royer P; Chauveau C; Asghar K; Tesson L; Lavainne F; Rémy S; Brion R; Hubert FX; Heslan M; Rimbert M; Berthelot L; Moffett JR; Josien R; Grégoire M; Anegon I
    Eur J Immunol; 2007 Nov; 37(11):3054-62. PubMed ID: 17948274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG).
    Sarkhosh K; Tredget EE; Karami A; Uludag H; Iwashina T; Kilani RT; Ghahary A
    J Cell Biochem; 2003 Sep; 90(1):206-17. PubMed ID: 12938169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells.
    Brenk M; Scheler M; Koch S; Neumann J; Takikawa O; Häcker G; Bieber T; von Bubnoff D
    J Immunol; 2009 Jul; 183(1):145-54. PubMed ID: 19535644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.
    Xu SQ; Wang CY; Zhu XJ; Dong XY; Shi Y; Peng J; Qin P; Sun JZ; Guo C; Ni H; Hou M
    Ann Hematol; 2012 Oct; 91(10):1623-31. PubMed ID: 22526360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of indoleamine 2,3-dioxygenase for alloimmunity and transplantation.
    Brandacher G; Margreiter R; Fuchs D
    Curr Opin Organ Transplant; 2008 Feb; 13(1):10-5. PubMed ID: 18660700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.
    Boasso A; Herbeuval JP; Hardy AW; Winkler C; Shearer GM
    Blood; 2005 Feb; 105(4):1574-81. PubMed ID: 15466932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunoregulatory role of IDO-producing human dendritic cells revisited.
    Terness P; Chuang JJ; Opelz G
    Trends Immunol; 2006 Feb; 27(2):68-73. PubMed ID: 16406698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction.
    Davis PM; Nadler SG; Stetsko DK; Suchard SJ
    Clin Immunol; 2008 Jan; 126(1):38-47. PubMed ID: 17945538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of indoleamine 2,3-dioxygenase in transplantation.
    Hainz U; Jürgens B; Heitger A
    Transpl Int; 2007 Feb; 20(2):118-27. PubMed ID: 17239019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction.
    Matteoli G; Mazzini E; Iliev ID; Mileti E; Fallarino F; Puccetti P; Chieppa M; Rescigno M
    Gut; 2010 May; 59(5):595-604. PubMed ID: 20427394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells.
    López AS; Alegre E; LeMaoult J; Carosella E; González A
    Mol Immunol; 2006 Jul; 43(14):2151-60. PubMed ID: 16490253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.